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The cause of a complex disease cannot be pinpointed
to a single origin; rather, a highly complex network of
many factors that interact on different levels over time
and space is disturbed. This complexity requires novel
approaches to diagnosis, treatment, and prevention.
To foster the necessary shift to a pro-active systems
medicine, proof-of-concept studies are needed. Here,
we highlight several systems approaches that have
been shown to work within the field of respiratory
medicine, and we propose the next steps for broader
implementation.integrating knowledge from various healthcare aspects,
ranging from clinical data to knowledge-based patientComplex disease management
Complex, non-communicable diseases, such as cardio-
vascular disease, cancers, diabetes, and chronic respira-
tory diseases (for example, chronic obstructive pulmonary
disease (COPD)), account for more than 60 % of deaths
worldwide [1]. Complex diseases result from multiple, dy-
namic interactions among various factors at different
spatiotemporal levels, and the classical or reductionist ap-
proach of treating one disease in isolation and as if it has
one origin is greatly challenged by a high degree of bio-
complexity. Reliable diagnostic, therapy, and prevention
strategies therefore need to integrate multiple factors
that influence disease, whether of internal origin (for ex-
ample, genetic predisposition, presence of biomarkers, or
spatiotemporal dynamics) or external origin (for example,
lifestyle, age, or fitness). This will allow a holistic under-
standing of health and disease and provide a view of
healthcare that is focused on the patient.* Correspondence: m.kirschner@fz-juelich.de
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effort is required. To cope with the enormous amount of
information that modern life sciences are able to generate,
clinicians need to integrate and interrelate data without
becoming IT experts. They need multi-level intervention
and prevention plans to monitor patient health states,
supported by information systems that assist in making
optimal decisions for diagnosis, treatment, and disease
prevention. Such a development needs both healthcare or-
ganizations and reimbursement or insurance companies
to reconsider the classical symptomatic-based interven-
tion strategies, and to concentrate their attention on the
holistic approaches that systems medicine is able to offer.
We provide examples of the opportunity offered by
care, changes in lifestyle, clinical management and indi-
vidual system-based decisions for treatment. We discuss
how successful implementation of systems medicine needs
not only suitable informatics tools but also a clear
organizational infrastructure, both of which are dependent
on a proper financial framework. We also propose a con-
ceptual strategy for a systems-based healthcare framework
that focuses on reference sites and a stepwise approach to
implementation and scale-up.Proof of principle examples of systems medicine
Surveying the pilot projects for systems medicine within
European healthcare, it appears that progress is being
made in three areas: the use of reference sites that use a
patient-centric approach, the use of disease models and
technology to provide decision support software, and the
use of knowledge-management systems. We provide more
information on these areas below.
COPD affects about 10 % of the population and is a
major, life-threatening disease. If the patient is to be
placed at the center of the treatment plan, then a com-
prehensive understanding of the patient, their quality
of life, their acute and chronic health problems, andle is distributed under the terms of the Creative Commons Attribution 4.0
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changes were made. The Creative Commons Public Domain Dedication waiver
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approach taken by The Centre of Expertise for Chronic
Organ Failure (CIRO). This is an expertise center for
chronic disease care in The Netherlands and a pioneer
in the field of systems medicine. At this site, an inter-
disciplinary team, together with the patient, generates
an integrated care pathway built from multiple mod-
ules. The care pathway consists of a variety of basic
modules covering different disease dimensions, such as
dyspnea and exacerbation management, as well as cop-
ing and psychopathological aspects. Depending on the
baseline assessment information, step-up modules may
be added on top of this baseline management program.
To enable such a patient-centric approach, CIRO needed
to adapt workflows, processes, and decision-making pro-
cedures to enable a more holistic view of the patient’s
health and disease status. The care management shifted
from a fragmented disease-oriented approach to an
integrated approach delivered by a multidisciplinary
team of health care providers in partnership with the
patients.
Most healthcare systems are divided into clinical spe-
cialties, which prevent a coordinated approach to ther-
apy. The technology is now available, however, to shape
an innovative healthcare framework that implements
systems medicine concepts. Recently, several research
projects funded by the European Commission (e.g., Air-
PROM, Synergy-COPD, and SysCLAD) have developed
detailed computational models of whole-body systems that
are able to lead to validated, personalized predictions for
risk assessment and intervention strategies [2]. But beyond
the understanding of disease models, such as those for
COPD [2], technology needs to support individuals and
care personnel in acting upon the information generated.
Methods such as disease dashboards [3] and clinical deci-
sion support systems [4] provide technical solutions that
can simplify and deliver complex information summaries
and facilitate team-based approaches to care across mul-
tiple providers. Integration of these solutions into standard
care-management processes is becoming the norm in
some EU countries, such as the UK, although it is still
lacking in others.
The need to avoid unnecessary treatment can hardly
be overestimated. Operational excellence in terms of ef-
ficient and effective health care requires sophisticated
knowledge management to improve patient care, clin-
ical process management, and treatment strategies, and
to offer transparency in outcomes. In the case of CIRO,
a dedicated knowledge-management environment was
applied for optimal integration of all relevant informa-
tion, optimal patient stratification, and targeted therapy
approaches. The knowledge-management environment
offers the potential to analyze and integrate a wide var-
iety of clinical and diagnostic variables and to relateprogram outcomes to patient characteristics and com-
ponents of the management process. Initially focused
on COPD, this system now serves as a blueprint to be
applied in different disease areas and clinical settings.
The Clinic Hospital Barcelona followed a comple-
mentary approach to integrated care, which focused on
the exchange of knowledge across tertiary hospitals and
care personnel. A knowledge-sharing system enabled
the transfer of care-plan and case-management infor-
mation across the team. Key enabling factors were: the
willingness or even pressure from paying institutions to
include relevant outcome measures, such as patient adher-
ence or reduced hospitalization, which are summarized in
a multidimensional outcome index; changes to workflow
and business processes that are fostered and implemented
by the clinic management; and change management in
terms of the integration of care personnel and patients
into workflow planning and feedback.
Proposed implementation strategy
Although the heterogeneity of European healthcare sys-
tems presents some obstacles, this diversity also pro-
vides enormous potential. It is important to support
the exchange of experience in implementing new sys-
tems medicine infrastructures, to connect the initiatives
and to harmonize the activities. In accordance with the
European Innovation Partnership (www.ec.europa.eu)
and the European Connected Health Alliance analysis
on challenges and barriers to the introduction of
eHealth (www.echalliance.com), we propose the follow-
ing steps for the implementation of systems medicine
in healthcare.
(1)Establish stable local networks that continuously
bring together the key stakeholders: patients, care
managers, care personal, technology providers,
entrepreneurs, policy makers, and regulators.
(2)Implement reference sites to identify local barriers
and challenges.
(3)Exchange best-practice and experience between
reference sites to identify patterns of barriers and
possible solutions.
(4)Provide required framework adaptations (legal,
financial, regulatory, incentive, and educational
systems) to enable scale-up and replication.
This conceptual framework should be complemented by
strategies for implementing systems medicine approaches
in healthcare as discussed below.
Definition of success indicators
Indicators for a systems medicine approach to complex
diseases need to be clearly defined, and both hospitals
and insurance companies need to be able to make a
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measurable positive impact on care and quality of life
(based on quality-adjusted-life-years (QALY) and re-
duction in disease burden) could justify additional in-
vestments. We suggest building on the success of early
prototypes based on patient-centric systems medicine
that have provided tangible health and economic im-
pacts as a promising way to move forward.
Introduction of a measurable, multi-dimensional success
index
In order to convince payers to support innovative systems
approaches, a comprehensible, multidimensional success
index [5] must be developed. The efficacy of complex
interventions needs to be monitored together with the
differential response to such interventions in patients with
a multicomponent pathology such as COPD [6]. The pre-
paredness of payers to spur such a success index will
support, or even create, the necessary business process
change necessary to further support a systems medicine
approach. In addition, the efficiency indicators need to be
clearly defined so that both hospitals and insurance com-
panies are able to make a proper assessment of the socio-
economic benefits of systems medicine approaches to
complex diseases. At present, many healthcare systems
still lack such an index and payers still hesitate to focus on
true gains in treatment efficiency and patient quality of
life. Instead, numbers of interventions and hospital days
are too often the standard measures of efficiency.Systems Medicine Research 
(-omics technologies and modeling)
Care/therapy
Translation into practice: truly integrated approach










Fig. 1 Implementing systems medicine in practice. Patient health
is the driver for a future proactive P4 medicine that is predictive,
preventive, personalized, and participatory [7]. This approach is
supported by modern research, which includes both modern
-omics technologies and mathematical or computational
modeling, as an integral part of prediction and personalization.
Integrated care concepts deliver a participatory aspect that needs
support provided through prevention measures and proper back
up from public health strategies and related political decisionsFrom reactive to pro-active medicine
Lifelong, sustained patient health is the driver for the use
of systems medicine in medical research and practice, and
predictive, preventive, personalized, and participatory (P4
medicine [7]; Fig. 1) provides the most promising way
forward for pro-active medicine. Environmental factors,
such as diet, exercise, pollution, smoking, drug use, as well
as intrinsic genetic disposition have a more pronounced
impact on health than healthcare itself. Thus, a transition
towards focusing on disease prevention or delaying disease
onset will both contribute to individual health and reduce
the burden of disease on society. Here, systems medicine
has the potential to truly focus on the initial transition
from wellness to disease and to identify possible preven-
tion measures. This promises novel diagnostic and thera-
peutic strategies not only for preserving the wellness of
each individual but also for promoting a return to a
healthy state as soon as possible (Fig. 1).
Conclusion
In some complex diseases, the practical feasibility of a
systems medicine approach has already been proven suc-
cessful [8–10]. In order to develop the full potential of
systems medicine, a truly integrated approach involving
all relevant stakeholders is needed that is backed up by
well-defined studies, utilizing comprehensible efficiency
indicators and success indices that demonstrate socio-
economic benefits. Such a concept will have the greatest
potential for systems-based medicine that can significantly
reduce disease burden in the medium and long term.
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